Biorigin to invest $46 million in expansion plan
Biorigin, dedicated to the development of innovative
solutions from yeasts and derivatives, has announced the investment of US$46
million until the end of 2008 in its Operations and R&D units.
Biorgin's objective is to increase production capacity from 18,000 MT/year
to 35,000 MT/year at the end of 2008. The $40-million investment in the
productive unit is expected to double the fermentation, autolysis and also the
drying processes, thus contributing to the removal of some productive
The first phase of investments will be initiated in R&D unit that aims
at the twofold increase of the already existing area. Approx. $6 million will be
invested in the construction of two new buildings for the area.
One of the new buildings will be focused on fermentation to improve already
existing processes, as well as to develop new processes contributing the work of
constant search for ingredients with high added value.
The other building will hold the microbiology area and will be dedicated to
the study and discovery of microorganisms aiming at defined functionalities or
in the search for new applications.
The entire investment project in the R&D area of Biorigin deals with
the construction of eight new buildings similar in size and with different
To comment, login here
Or register to be able to comment.